Status:
RECRUITING
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Breast Cancer
Liver Metastases
Eligibility:
All Genders
18+ years
Brief Summary
The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immun...
Detailed Description
In this multicenter observational ambispective study, will be enrolled all patients with BCLM underwent liver resection or medical treatment alone afferent to the Fondazione Policlinico Gemelli IRCSS ...
Eligibility Criteria
Inclusion
- \> 18 years old
- BCLM
- BCLM and extra-hepatic disease
- Any treatment
- Ability to understand and sign the informed consent
Exclusion
- Inability to provide the informed consent
- Patient who underwent Best Supportive Care or Palliation
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT06093022
Start Date
April 1 2018
End Date
December 31 2028
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Lazio, Italy, 00168